Melanoma

• Gebundenes Buch

Produktbeschreibung

This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of melanoma treatment. Due to recent drug approvals and increasing ability to offer combined agents, there are many more treatment options available to melanoma patients than even a few years ago. Especially significant are the recent FDA approval of the immunotherapeutic agent ipilimumab for metastatic melanoma, and new agents targeting the BRAF gene in malignant melanoma (these two developments cited among the top 5 most significant advances in oncology for 2011). There is also coverage of the most recent data pertaining to surgical management, staging and prevention, and melanoma in children. The authorship of the articles is outstanding and represents national and global authorities on the topics reviewed.

Produktdetails

• Verlag: Springer Publishing Company
• Seitenzahl: 240
• Erscheinungstermin: 17. Dezember 2012
• Englisch
• Abmessung: 259mm x 178mm x 15mm
• Gewicht: 726g
• ISBN-13: 9781936287796
• ISBN-10: 193628779X
• Artikelnr.: 36058177

Inhaltsangabe

"1. Preventing Melanoma
Barbara Summerer
MD
Sewon Kang
MD
and Timothy Wang
MD
2. Evolution of the Melanoma Staging System
Rohit R. Sharma
Glen C. Balch
and Charles M. Balch
3. Less Common Variants of Cutaneous Melanoma
Raymond L. Barnhill and Kapil Gupta
4. Controversies in the Management of the Regional Node Basin in Cutaneous Melanoma
Ioannis Hatzaras and Julie R. Lange
5. Adjuvant Therapy for Melanoma
Tara C. Gangadhar and Lynn M. Schuchter
6. RAF Kinase Inhibitor Therapy in Melanoma
James J. Harding and Paul B. Chapman
7. Emerging Targets for Melanoma Therapy Besides BRAF
Young Kwang Chae
Sapna P. Patel
and Kevin B. Kim
8. Ipilimumab: The New Frontier of T-Cell Antibodies: A Paradigm Shift in Immuno-Oncology
Steven J. O'Day
9. Adoptive Cell Transfer Immunotherapy for Patients with Metastatic Melanoma
Crystal J. Hessman
Ashley A. Stewart
Akemi D. Miller
James C. Yang
and Steven A. Rosenberg
10. Immunotherapies for Metastatic Melanoma
Kevin Conlon
11. Updated Approach to the Patient with Metastatic Melanoma
Rodabe N. Amaria and Rene Gonzalez; ; "